Antihistamine Shows Promise in Reversing Multiple Sclerosis.

A new study has identified the over-the-counter antihistamine, clemastine, as an effective drug for brain repair in Multiple Sclerosis (MS) patients. Using a newly-developed MRI scan technique, scientists were able to observe and measure the impact of clemastine on brain myelin levels. The study offers the first documented example of brain repair for a chronic neurological condition through MRI and is expected to set a standard for future research into myelin-rebuilding therapies. Clemastine is also being considered for use in treating brain injury in premature infants, who often experience myelin damage.